12:00 AM
 | 
Jul 15, 2013
 |  BC Week In Review  |  Company News  |  Management Tracks

Idera board of directors update

Idera Pharmaceuticals Inc. (NASDAQ:IDRA), Cambridge, Mass.
Business: Cancer, Infectious, Autoimmune...

Read the full 28 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >